Galectin Therapeutics (GALT) Current Leases (2020 - 2026)
Galectin Therapeutics' (GALT) quarterly Current Leases came in at $6000.0 in Q1 2026, down 91.18% year-on-year from $68000.0 in Q1 2025, and down 72.73% quarter-over-quarter from $22000.0 in Q4 2025.
Galectin Therapeutics (GALT) Current Leases (2020 - 2026) Analysis & Trends
Galectin Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $6000.0 for Q1 2026.
- On a quarterly basis, Current Leases fell 91.18% year-over-year to $6000.0 in Q1 2026; TTM through Mar 2026 was $6000.0, a 91.18% decrease from a year earlier, with the FY2025 full-year figure at $22000.0, up 15.79% from the prior year.
- Current Leases retreated to $6000.0 in Q1 2026 per GALT's latest filing, from $22000.0 in the prior quarter.
- Across five years, Current Leases topped out at $68000.0 in Q1 2025 and bottomed at $6000.0 in Q1 2026.
- The 5-year median for Current Leases is $40000.0 (2022), against an average of $36764.7.
- Across the five-year window, Current Leases surged 400.0% in 2022 and plunged 91.18% in 2026, its largest moves.
- Year by year, Current Leases stood at $40000.0 in 2022, then increased by 15.0% to $46000.0 in 2023, then plunged by 58.7% to $19000.0 in 2024, then advanced by 15.79% to $22000.0 in 2025, then sank by 72.73% to $6000.0 in 2026.
- Per Business Quant, the three latest GALT Current Leases figures stand at $6000.0 (Q1 2026), $22000.0 (Q4 2025), and $37000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Galectin Therapeutics | 227.21 Mn | 227.21 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Mar 31, 2025 | 68,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Dec 31, 2020 | 44,000.00 |